TrialJournal of immunology (Baltimore, Md. : 1950)2011

Increased T cell proliferative responses to islet antigens identify clinical responders to anti-CD20 monoclonal antibody (rituximab) therapy in type 1 diabetes.

Kevan C Herold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.